captopril has been researched along with Nerve Degeneration in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coleman, C; Gadad, BS; German, DC; Harris, SL; Li, W; Richardson, JR; Sonsalla, PK; Wong, LY | 1 |
| AbdAlla, S; Abdelbaset, A; El Hakim, A; Elfaramawy, Y; Quitterer, U | 1 |
| Flora, SJ; Mehta, A; Mishra, D; Pachauri, V; Saxena, G | 1 |
| Guerra, MJ; Labandeira-Garcia, JL; Mendez-Alvarez, E; Muñoz, A; Rey, P; Soto-Otero, R | 1 |
4 other study(ies) available for captopril and Nerve Degeneration
| Article | Year |
|---|---|
The angiotensin converting enzyme inhibitor captopril protects nigrostriatal dopamine neurons in animal models of parkinsonism.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Brain; Captopril; Dopaminergic Neurons; Immunohistochemistry; Male; Mice; MPTP Poisoning; Nerve Degeneration; Neuroprotective Agents; Rats | 2013 |
Inhibition of ACE Retards Tau Hyperphosphorylation and Signs of Neuronal Degeneration in Aged Rats Subjected to Chronic Mild Stress.
Topics: Alzheimer Disease; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; gamma-Synuclein; Gene Expression Regulation; Glutamate Decarboxylase; Hippocampus; Humans; Microtubule-Associated Proteins; Nerve Degeneration; Neurons; Peptidyl-Dipeptidase A; Phosphorylation; Rats; tau Proteins | 2015 |
Combinational chelation therapy abrogates lead-induced neurodegeneration in rats.
Topics: Animals; Antioxidants; Apoptosis; Behavior, Animal; Biogenic Amines; Calcium; Captopril; Chelating Agents; Cytochromes c; Disease Models, Animal; DNA Damage; Drug Therapy, Combination; Exploratory Behavior; Lead Poisoning, Nervous System; Learning; Male; Membrane Potential, Mitochondrial; Memory; Mitochondria; Motor Activity; Nerve Degeneration; Neurons; Nitric Oxide; Organometallic Compounds; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Succimer | 2009 |
Reduction of dopaminergic degeneration and oxidative stress by inhibition of angiotensin converting enzyme in a MPTP model of parkinsonism.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Angiotensin-Converting Enzyme Inhibitors; Animals; Antiparkinson Agents; Captopril; Dopamine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Immunohistochemistry; In Vitro Techniques; Lipid Peroxidation; Male; Mesencephalon; Mice; Mice, Inbred C57BL; Mitochondria; Monoamine Oxidase; Neostriatum; Nerve Degeneration; Nerve Endings; Nerve Tissue Proteins; Neuroprotective Agents; Oxidative Stress; Parkinson Disease, Secondary; Pyridinium Compounds; Synaptosomes; Tyrosine 3-Monooxygenase | 2006 |